Trodelvy, also known as sacituzumab govitecan, is a medication used for the treatment of various types of cancer. This innovative drug has demonstrated promising results in patients with metastatic triple-negative breast cancer and metastatic urothelial cancer who have previously received specific types of treatment. Developed as a potential therapy for difficult-to-treat cancers, Trodelvy has brought […]
Trodelvy injection is a medication used in the treatment of specific types of cancer, particularly metastatic triple-negative breast cancer (mTNBC) and metastatic urothelial cancer. It is classified as an antibody-drug conjugate that targets cancer cells, inhibiting their growth and proliferation. Trodelvy has demonstrated significant efficacy in treating certain difficult-to-treat cancers, offering a promising therapeutic option […]